ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Infinity Pharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – INF Sep 28, 2023 05:00PM
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Infinity Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – INFI Sep 17, 2023 04:49PM
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Infinity Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – INFI Sep 12, 2023 08:15PM
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Infinity Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – INFI Sep 6, 2023 03:36PM
MEI Pharma Reminds Shareholders to Vote Today FOR the Infinity Transaction Jul 19, 2023 08:00AM


Jul 17, 2023 08:00AM MEI Pharma Encourages Shareholders to Vote FOR the Infinity Transaction
Jul 11, 2023 08:00AM MEI Pharma Provides Final Reminder to Shareholders to Vote Today FOR the Merger With Infinity Pharmaceuticals
Jul 7, 2023 08:00AM MEI Pharma Reminds Shareholders to Vote FOR the Merger with Infinity Pharmaceuticals
Jul 5, 2023 08:00AM MEI Pharma Highlights Recommendation by Leading Independent Proxy Advisory Firm ISS to Vote “FOR” Pending Transaction with Infinity Pharmaceuticals
Jun 29, 2023 08:02AM MEI Pharma (MEIP) Issues Letter to Shareholders
Jun 29, 2023 08:00AM MEI Pharma Mails Letter to Shareholders Reiterating Value Creating Potential of Proposed Transaction with Infinity Pharmaceuticals
Jun 15, 2023 12:08PM MEI Pharma and Infinity Pharmaceuticals Host Video Webcast Providing Overview and Update on Pending Merger to Advance Three Promising Clinical Oncology Candidates
Jun 15, 2023 08:00AM MEI Pharma and Infinity Pharmaceuticals Host Video Webcast Providing Overview and Update on Pending Merger to Advance Three Promising Clinical Oncology Candidates
Feb 23, 2023 07:05AM MEI Pharma (MEIP) and Infinity Pharmaceuticals (INFI) Announce Merger Agreement
Feb 23, 2023 07:00AM MEI Pharma and Infinity Pharmaceuticals Announce Definitive Merger Agreement to Advance Three Promising Clinical Oncology Candidates
Nov 5, 2018 07:00AM Bristol-Myers Squibb (BMY), Infinity Pharmaceuticals (INFI) Reports New Clinical Collaboration to Evaluate Opdivo (Nivolumab) in Combination with IPI-549 in Urothelial Cancer
Nov 5, 2018 06:59AM Bristol-Myers Squibb and Infinity Pharmaceuticals Announce a New Clinical Collaboration to Evaluate Opdivo (Nivolumab) in Combination with IPI-549 in Urothelial Cancer
Nov 5, 2018 06:59AM Bristol-Myers Squibb and Infinity Pharmaceuticals Announce a New Clinical Collaboration to Evaluate Opdivo (Nivolumab) in Combination with IPI-549 in Urothelial Cancer
Nov 9, 2016 07:00AM Bristol-Myers Squibb (BMY), Infinity Pharma (INFI) Enter Advanced Solid Tumors-Focused Collaboration
Nov 9, 2016 06:59AM Bristol-Myers Squibb and Infinity Pharmaceuticals Announce Clinical Collaboration to Evaluate Opdivo (Nivolumab) in Combination with IPI-549 in Advanced Solid Tumors
Nov 9, 2016 06:59AM Bristol-Myers Squibb and Infinity Pharmaceuticals Announce Clinical Collaboration to Evaluate Opdivo (nivolumab) in Combination with IPI-549 in Advanced Solid Tumors